CD274 and non-small cell lung carcinoma: Furthermore, the advanced immunotherapy for NSCLC patients may require an accurate N stage, since a discrepant programmed death-ligand 1 (PD-L1) expression was observed between primary tumors and nodal metastases of NSCLC (25).